(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.
Authors : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P Year : 2022 Journal : J Nucl Med
Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.
Authors : Manta R, Delbart W, Duran Derijckere I, Quiriny M, Demetter P, Flamen P, Karfis I Year : 2022 Journal : Eur J Hybrid Imaging
Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
Authors : Chan DL, Hayes AR, Karfis I, Conner A, Furtado OMahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL Year : 2022 Journal : Br J Cancer
Authors : Lifrange F, de Wind R, Spilleboudt C, Karfis I, Van Gossum A, Demetter P Year : 2021 Journal : Acta Gastroenterol Belg
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell lines.
Authors : Delbart W, Ghanem G, Karfis I, Flamen P, Wimana Z Year : 2021 Journal : Nucl Med Biol